-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Reiterates Market Outperform on Taysha Gene Therapies, Maintains $11 Price Target

Benzinga·07/02/2026 12:56:03
Listen to the news
Citizens analyst Silvan Turkcan reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Market Outperform and maintains $11 price target.